Download PDF Flyer
Impact Factor Current: 2.196
5 - Year: 2.849

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Latest Issue: Volume 19 , Issue 10 , 2019

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 2.196
5 - Year: 2.849

Ranking & Category

  • 82nd of 133 in Medicine, research & Experimental

Topics Covered

1 Topics

View
Covered Diseases

0 Diseases

View

Aims & Scope

Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.

Abstracted/Indexed in


Science Citation Index Expanded™, Journal Citation Reports/Science Edition, InCites, Biotechnology Citation Index®, Current Contents® - Life Sciences, Current Contents® - Clinical Medicine, Index to Scientific Reviews®, ISI Alerting Services, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/PubMed/Index Medicus, Scopus, EMBASE/Excerpta Medica, Chemical Abstracts Service/SciFinder, ProQuest, ChemWeb, Google Scholar, Genamics JournalSeek, Cabell's Directory, MediaFinder®-Standard Periodical Directory, EMBiology, PubsHub, Index Copernicus, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, British Library, Ulrich's Periodicals Directory and JournalTOCs.

Announcements
Endorsement(s)
"A critically important journal that fills an important niche."

David Weiner
Pennsylvania School of Medicine, USA
Authors' Comments

My experience working with Bentham Science Publishers was excellent and among the best I've had with publishing anywhere. I worked with Ms. Samina Khan at Bentham. She was prompt to respond and her responses were always helpful. We have had a number of correspondences and she always worked things through to completion.


John Paul SanGiovanni
(National Eye Institute, Bethesda, USA)

Has contributed: Application and Interpretation of Genome-Wide Association (GWA) Studies for Informing Pharmacogenomic Research – Examples from the Field of Age-Related Macular Degeneration
© 2019 Bentham Science Publishers